NCT05378100View on ClinicalTrials.gov

Ketamine for Multiple Sclerosis Fatigue

PHASE2RecruitingINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

March 1, 2026

Conditions

Multiple Sclerosis Fatigue

Interventions

DRUG

Ketamine

Infusion of ketamine 0.5 mg/kg over 40 minutes

DRUG

Midazolam

Infusion of midazolam 0.05 mg/kg over 40 minutes

Trial Locations (1)

21287

RECRUITING

Johns Hopkins University, Baltimore

All Listed Sponsors

collaborator

United States Department of Defense

FED

lead

Johns Hopkins University

OTHER